These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32833316)

  • 1. Regulating CRISPR/Cas9 Function through Conditional Guide RNA Control.
    Brown W; Zhou W; Deiters A
    Chembiochem; 2021 Jan; 22(1):63-72. PubMed ID: 32833316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A catalogue of biochemically diverse CRISPR-Cas9 orthologs.
    Gasiunas G; Young JK; Karvelis T; Kazlauskas D; Urbaitis T; Jasnauskaite M; Grusyte MM; Paulraj S; Wang PH; Hou Z; Dooley SK; Cigan M; Alarcon C; Chilcoat ND; Bigelyte G; Curcuru JL; Mabuchi M; Sun Z; Fuchs RT; Schildkraut E; Weigele PR; Jack WE; Robb GB; Venclovas Č; Siksnys V
    Nat Commun; 2020 Nov; 11(1):5512. PubMed ID: 33139742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision Genome Editing with CRISPR-Cas9.
    Rahman S; Ikram AR; Azeem F; Tahir Ul Qamar M; Shaheen T; Mehboob-Ur-Rahman
    Methods Mol Biol; 2024; 2788():355-372. PubMed ID: 38656525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Control of Genome Editing by Photoactivatable Cas9.
    Otabe T; Nihongaki Y; Sato M
    Methods Mol Biol; 2021; 2312():225-233. PubMed ID: 34228293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single molecule methods for studying CRISPR Cas9-induced DNA unwinding.
    Okafor IC; Choi J; Ha T
    Methods; 2022 Aug; 204():319-326. PubMed ID: 34767923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-step genome editing of porcine zygotes through the electroporation of a CRISPR/Cas9 system with two guide RNAs.
    Hirata M; Wittayarat M; Tanihara F; Sato Y; Namula Z; Le QA; Lin Q; Takebayashi K; Otoi T
    In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):614-621. PubMed ID: 32978715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
    Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
    Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Manipulation Using Fusion Guide RNAs for Cas9 and Cas12a.
    Shin HR; Kweon J; Kim Y
    Methods Mol Biol; 2021; 2162():185-193. PubMed ID: 32926383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrypting the mechanistic basis of CRISPR/Cas9 protein.
    Panda G; Ray A
    Prog Biophys Mol Biol; 2022 Aug; 172():60-76. PubMed ID: 35577099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR/Cas9-Mediated Genome Editing of Trichoderma reesei.
    Zou G; Zhou Z
    Methods Mol Biol; 2021; 2234():87-98. PubMed ID: 33165782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting back malaria: CRISPR/Cas9 genome editing of Plasmodium.
    Lee MCS; Lindner SE; Lopez-Rubio JJ; Llinás M
    Brief Funct Genomics; 2019 Sep; 18(5):281-289. PubMed ID: 31365053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lentivirus-based system for Cas9/gRNA expression and subsequent removal by Cre-mediated recombination.
    Carpenter MA; Law EK; Serebrenik A; Brown WL; Harris RS
    Methods; 2019 Mar; 156():79-84. PubMed ID: 30578845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements.
    Lattanzi A; Meneghini V; Pavani G; Amor F; Ramadier S; Felix T; Antoniani C; Masson C; Alibeu O; Lee C; Porteus MH; Bao G; Amendola M; Mavilio F; Miccio A
    Mol Ther; 2019 Jan; 27(1):137-150. PubMed ID: 30424953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an Inducible CRISPR/Cas9 System for CXCR4 Gene and Demonstration of its Effects on MKN-45 Cells.
    Peng Y; Yang T; Tang X; Chen F; Wang S
    Cell Biochem Biophys; 2020 Mar; 78(1):23-30. PubMed ID: 31875277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.
    Gramelspacher MJ; Hou Z; Zhang Y
    Methods; 2020 Feb; 172():32-41. PubMed ID: 31228550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal 2'-O-methyl phosphorothioate linkage modification pattern of synthetic guide RNAs for increased stability and efficient CRISPR-Cas9 gene editing avoiding cellular toxicity.
    Basila M; Kelley ML; Smith AVB
    PLoS One; 2017; 12(11):e0188593. PubMed ID: 29176845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.
    Sugano SS; Nishihama R
    Methods Mol Biol; 2018; 1830():109-126. PubMed ID: 30043367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal Control of CRISPR/Cas9 Function in Cells and Zebrafish using Light-Activated Guide RNA.
    Zhou W; Brown W; Bardhan A; Delaney M; Ilk AS; Rauen RR; Kahn SI; Tsang M; Deiters A
    Angew Chem Int Ed Engl; 2020 Jun; 59(23):8998-9003. PubMed ID: 32160370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational and experimental performance of CRISPR homing gene drive strategies with multiplexed gRNAs.
    Champer SE; Oh SY; Liu C; Wen Z; Clark AG; Messer PW; Champer J
    Sci Adv; 2020 Mar; 6(10):eaaz0525. PubMed ID: 32181354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.